Corrado Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-18,831
| Closed | -$731K | – | 107 |
|
|
2024
Q4 | $731K | Buy |
18,831
+2,775
| +17% | +$108K | 0.48% | 81 |
|
|
2024
Q3 | $723K | Buy |
16,056
+473
| +3% | +$21.3K | 0.45% | 79 |
|
|
2024
Q2 | $651K | Buy |
15,583
+973
| +7% | +$40.6K | 0.42% | 83 |
|
|
2024
Q1 | $665K | Buy |
14,610
+808
| +6% | +$36.8K | 0.44% | 75 |
|
|
2023
Q4 | $638K | Buy |
+13,802
| New | +$638K | 0.52% | 61 |
|